The Latest Breaking News from Kritika SarmahHer

Following a year of solid growth in 2022, leading pharma company AstraZeneca’s (AZN) robust pipeline and recent launches look promising. Moreover, its strong fundamentals should enable the stock to deliver solid returns this year. So, AZN could be an ideal buy. Keep reading.

With inflation still alarmingly high, the Fed’s rate hikes might continue. This is raising concerns over the possibility of a recession. Therefore, quality dividend-paying stocks Altria (MO), International Paper (IP), ICL Group (ICL), and Spok (SPOK), yielding more than 4%, might be ideal buys now. Read more.

Sticky inflation might trigger more rate hikes this year, which could keep the stock market under pressure. Hence, investors could consider buying fundamentally strong stocks Stellantis (STLA), Honda Motor (HMC), MasterCraft Boat (MCFT), and Genie Energy (GNE) given the uncertainties. These stocks are rated A (Strong Buy) in our proprietary…

The airline industry has been struggling with macroeconomic issues, which is expected to keep fundamentally weak stock Spirit Airlines (SAVE) under pressure in the near term. In addition, while the space economy may command a significantly high valuation in the long run, the near-term prospects look beak on Virgin Galactic…

Leading pharma company Bristol-Myers Squibb’s (BMY) fiscal year 2022 revenue and EPS were in line with analysts’ estimates. While BMY continues to advance its innovative portfolio and pipeline, is it a good dividend stock to pick up right now? Read more to find out.

Leading networking company Nokia (NOK) announced robust growth in the fiscal year 2022. Moreover, the company looks confident in its near-term performance. And given bullish analysts’ expectations, NOK might be worth buying this month. Read more.

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

The rapid adoption of innovative technologies and growing sustainability and vertical farming initiatives should boost the global agriculture market. Hence, fundamentally strong agricultural stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), and Dole (DOLE) could be ideal buys now. However, considering the macro headwinds, fundamentally weak Cronos Group (CRON) might be best avoided.…

Despite macroeconomic headwinds, total industrial production rose in January. Moreover, robust government investments and technological advancements are boosting the sector’s prospects. Hence, quality industrial stocks General Electric (GE), Watts Water Technologies (WTS), and Core Molding Technologies (CMT) might be ideal buys. Read more.

Sticky inflation and looming recessionary fears might keep the cruise line industry under pressure this year. Hence, fundamentally weak cruise line stocks Royal Caribbean Cruises (RCL), Carnival (CCL), and Norwegian Cruise Line (NCLH) might be best sold short or completely avoided in 2023. Read more.

Consumers showing resiliency in the face of rising inflation have helped the U.S. GDP to come in better than expected in the last quarter. Moreover, hopes of the economy avoiding a deep recession this year are rising. The Nasdaq Composite began this year on a positive note. Hence, fundamentally strong…